Evidence map›Paper›PMID 36130558›Full record

ArticleJournal of neurosurgery. Case lessons2022

Malignant transformation of central neurocytoma with dissemination 17 years after initial treatment: illustrative case.

Kazuhiro Kojima, Yoshiki Arakawa, Yasuhide Takeuchi, Yukinori Terada, Masahiro Tanji, Yohei Mineharu, Hironori Haga, Susumu Miyamoto

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kazuhiro KojimaDepartments of1Neurosurgery and.
Yoshiki ArakawaDepartments of1Neurosurgery and.
Yasuhide Takeuchi2Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yukinori TeradaDepartments of1Neurosurgery and.
Masahiro TanjiDepartments of1Neurosurgery and.
Yohei MineharuDepartments of1Neurosurgery and.
Hironori Haga2Diagnostic Pathology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Susumu MiyamotoDepartments of1Neurosurgery and.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCentral neurocytomas usually have a favorable clinical course, and gross total resection (GTR) results in long-term survival. Recurrences of central neurocytomas are usually local, and dissemination is extremely rare. OBSERVATIONS: A 24-year-old man who presented with vomiting was found to have a mass in the right lateral ventricle. After GTR, he received whole-brain irradiation and chemotherapy and had remained disease-free on follow-up for years. The review of the initial tumor revealed central neurocytoma. Seventeen years later, he presented with deterioration of memory, and magnetic resonance imaging showed an enhanced lesion in the left hippocampus. The enhanced lesion was resected, and the histological examination revealed that the tumor was a disseminated atypical central neurocytoma with frequent mitoses. Although he was treated with chemotherapy, the disseminated tumor slowly grew and invaded the brain. Massive brain invasion occurred without enhanced lesions, and he died 27 months after the tumor recurrence. LESSONS: In this patient, a central neurocytoma disseminated after an extremely long period of time. Once neurocytomas disseminate and show aggressive behavior, patients usually follow a poor course. Patients with central neurocytomas should be followed up for a long time.

Indexed as

atypical neurocytomabrain invasioncentral neurocytomadisseminationrecurrence

Identifiers

PMID36130558
PMCPMC9379763
OpenAlexW4210903576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.